Synopsis
Synopsis
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Cavinton
2. Ethyl Apovincaminate
3. Ethyl Apovincaminate Tartrate (1:1)
4. Ethyl Apovincaminate, (+-)-isomer
5. Ethyl Apovincaminate, (16alpha)-isomer
6. Ethyl Apovincaminate, (3alpha,16alpha)-isomer
7. Ethyl Apovincaminate, 2-oxopentanedioate (1:1)
8. Ethyl Apovincaminate, 3h-labeled
9. Kavinton
10. Rgh-4405
11. Tcv-3b
1. 42971-09-5
2. Cavinton
3. Ceractin
4. Apovincaminic Acid Ethyl Ester
5. Bravinton
6. Ethyl Apovincamin-22-oate
7. Ultra-vinca
8. Tcv-3b
9. Rgh 4405
10. Ethyl (+)-apovincaminate
11. Vinporal
12. Cis-apovincaminic Acid Ethyl Ester
13. Rgh-4405
14. Ethyl (+)-cis-apovincaminate
15. Tcv 3b
16. (+)-apovincaminic Acid Ethyl Ester
17. Ethyl Apovincaminate
18. (+)-cis-apovincaminic Acid Ethyl Ester
19. Ay 27,255
20. 3-alpha,16-alpha-apovincaminic Acid Ethyl Ester
21. Nsc-760093
22. Chembl71752
23. Ay-27,255
24. Mls000069635
25. 543512obtc
26. (41s,13as)-ethyl 13a-ethyl-2,3,41,5,6,13a-hexahydro-1h-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
27. Ncgc00018204-09
28. Vinpocetinum
29. Ay-27255
30. Smr000058241
31. Eburnamenine-14-carboxylic Acid, Ethyl Ester, (3alpha,16alpha)-
32. Dsstox_cid_3740
33. Dsstox_rid_77176
34. Dsstox_gsid_23740
35. Ethyl (41s,13as)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1h-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
36. Vinpocetinum [inn-latin]
37. Eburnamenine-14-carboxylic Acid, Ethyl Ester, (3a,16a)-
38. Apovincaminate D'ethyle
39. Apovincaminate D'ethyle [french]
40. Ethyl (15s,19s)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene-17-carboxylate
41. Eburnamenine-14-carboxylic Acid Ethyl Ester
42. Sr-01000075633
43. Einecs 256-028-0
44. Brn 0900803
45. Vinpocetin
46. Unii-543512obtc
47. Vinpocetine (jan/usan/inn)
48. Vinpocetine-ethyl Apovincaminate
49. 3a,16a-apovincaminic Acid Ethyl Ester
50. Ncgc00016854-03
51. Vinpocetine [usan:inn:ban:jan]
52. Prestwick_963
53. Vinpocetin- Bio-x
54. Cas-42971-09-5
55. Mfcd00211233
56. Spectrum_001400
57. Vinpocetine (cavinton)
58. Ay 27255
59. Specplus_000327
60. Vinpocetine [mi]
61. Opera_id_1325
62. Prestwick0_000268
63. Prestwick1_000268
64. Prestwick2_000268
65. Prestwick3_000268
66. Spectrum2_001529
67. Spectrum3_000961
68. Spectrum4_001075
69. Spectrum5_000966
70. Vinpocetine [dsc]
71. Vinpocetine [inn]
72. Vinpocetine [jan]
73. Vinpocetine [usan]
74. V 6383
75. Vinpocetine [vandf]
76. Vinpocetine [mart.]
77. Lopac0_001257
78. Schembl50081
79. Bspbio_000116
80. Bspbio_002561
81. Kbiogr_001430
82. Kbioss_001880
83. Vinpocetine [usp-rs]
84. Vinpocetine [who-dd]
85. Mls001076294
86. Divk1c_006423
87. Spectrum1503115
88. Vinpocetine, >=98%, Solid
89. Ethyl (3alpha,16alpha)-eburnamenine-14-carboxylate
90. Spbio_001318
91. Spbio_002335
92. Bpbio1_000128
93. Cid_443955
94. Gtpl5285
95. Vinpocetine, Analytical Standard
96. Dtxsid5023740
97. Regid_for_cid_443955
98. Chebi:32297
99. Kbio1_001367
100. Kbio2_001880
101. Kbio2_004448
102. Kbio2_007016
103. Kbio3_001781
104. Hms1568f18
105. Hms1922g05
106. Hms2090j22
107. Hms2092l06
108. Hms2095f18
109. Hms3263l16
110. Hms3402d12
111. Hms3411h11
112. Hms3675h11
113. Hms3712f18
114. Hms3887e17
115. Pharmakon1600-01503115
116. Vinpocetine [ep Monograph]
117. (3alpha, 16alpha)-eburnamenine-14-carboxylic Acid Ethyl Ester
118. 68780-77-8
119. Amy39087
120. Bcp04123
121. Tox21_110648
122. Tox21_110839
123. Tox21_501257
124. Bdbm50059033
125. Ccg-39307
126. Eburnamenine-14-carboxylic Acid, Ethyl Ester, (3-alpha,16-alpha)-
127. Nsc760093
128. Pd-185
129. S2110
130. Zinc19796031
131. Akos015896480
132. Tox21_110648_1
133. Cs-0545
134. Db12131
135. Lp01257
136. Nsc 760093
137. Sdccgsbi-0051224.p003
138. Vinpocetine 1.0 Mg/ml In Acetonitrile
139. (3s,16s)-apovincaminic Acid Ethylester
140. Ncgc00018204-05
141. Ncgc00018204-06
142. Ncgc00018204-07
143. Ncgc00018204-08
144. Ncgc00018204-10
145. Ncgc00018204-11
146. Ncgc00018204-13
147. Ncgc00021727-04
148. Ncgc00021727-05
149. Ncgc00021727-06
150. Ncgc00021727-07
151. Ncgc00168782-01
152. Ncgc00261942-01
153. Ncgc00263865-01
154. Ncgc00263865-04
155. Ac-22612
156. As-13868
157. Bv164528
158. Hy-13295
159. Eburnamenine-14-carboxylic Acid Ethyl Ester;
160. Eu-0101257
161. V0115
162. D01371
163. Ab00052317_02
164. 971v095
165. Q420288
166. Sr-01000000118
167. Sr-01000000118-3
168. Sr-01000075633-1
169. Sr-01000075633-3
170. Sr-01000075633-4
171. W-202748
172. Brd-k53318339-001-05-8
173. (3?,16?)-eburnamenine-14-carboxylic Acid Ethyl Ester
174. Vinpocetine, European Pharmacopoeia (ep) Reference Standard
175. Vinpocetine, United States Pharmacopeia (usp) Reference Standard
176. Eburnamenine 14-carboxylic Acid Ethyl Ester (3.alpha.,16.alpha.)
177. (11as,11bs)-11a-ethyl-2,3,4,5,11a,11b-hexahydro-1h-3a,9b-diaza-benzo[cd]fluoranthene-10-carboxylic Acid Ethyl Ester
178. (3as,11bs)-3a-ethyl-1,2,3,3a,10,11b-hexahydro-11h-5a,11a-diaza-benzo[cd]fluoranthene-5-carboxylic Acid Ethyl Ester
179. (41s,13as)-ethyl13a-ethyl-2,3,41,5,6,13a-hexahydro-1h-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
180. 115986-87-3
181. 11a-ethyl-2,3,4,5,11a,11b-hexahydro-1h-3a,9b-diaza-benzo[cd]fluoranthene-10-carboxylic Acid 2-nitrooxy-ethyl Ester(vinpocetine)
182. Ethyl (15s,19s)-15-ethyl-1,11-diazapentacyclo[9.6.2.0^{2,7}.0^{8,18}.0^{15,19}]nonadeca-2(7),3,5,8(18),16-pentaene-17-carboxylate
183. Ethyl (15s,19s)-15-ethyl-1,11-diazapentacyclo[9.6.2.0^{2,7}.0^{8,18}.0^{15,19}]nonadeca-2,4,6,8(18),16-pentaene-17-carboxylate
| Molecular Weight | 350.5 g/mol |
|---|---|
| Molecular Formula | C22H26N2O2 |
| XLogP3 | 4.1 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 4 |
| Exact Mass | 350.199428076 g/mol |
| Monoisotopic Mass | 350.199428076 g/mol |
| Topological Polar Surface Area | 34.5 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 617 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Neuroprotective Agents
Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)
Phosphodiesterase Inhibitors
Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. (See all compounds classified as Phosphodiesterase Inhibitors.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Nootropic Agents
Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. (See all compounds classified as Nootropic Agents.)
N - Nervous system
N06 - Psychoanaleptics
N06B - Psychostimulants, agents used for adhd and nootropics
N06BX - Other psychostimulants and nootropics
N06BX18 - Vinpocetine
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Vinpocetine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vinpocetine, including repackagers and relabelers. The FDA regulates Vinpocetine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vinpocetine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Vinpocetine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Vinpocetine supplier is an individual or a company that provides Vinpocetine active pharmaceutical ingredient (API) or Vinpocetine finished formulations upon request. The Vinpocetine suppliers may include Vinpocetine API manufacturers, exporters, distributors and traders.
click here to find a list of Vinpocetine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Vinpocetine DMF (Drug Master File) is a document detailing the whole manufacturing process of Vinpocetine active pharmaceutical ingredient (API) in detail. Different forms of Vinpocetine DMFs exist exist since differing nations have different regulations, such as Vinpocetine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Vinpocetine DMF submitted to regulatory agencies in the US is known as a USDMF. Vinpocetine USDMF includes data on Vinpocetine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Vinpocetine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Vinpocetine suppliers with USDMF on PharmaCompass.
A Vinpocetine CEP of the European Pharmacopoeia monograph is often referred to as a Vinpocetine Certificate of Suitability (COS). The purpose of a Vinpocetine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Vinpocetine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Vinpocetine to their clients by showing that a Vinpocetine CEP has been issued for it. The manufacturer submits a Vinpocetine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Vinpocetine CEP holder for the record. Additionally, the data presented in the Vinpocetine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Vinpocetine DMF.
A Vinpocetine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Vinpocetine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Vinpocetine suppliers with CEP (COS) on PharmaCompass.
A Vinpocetine written confirmation (Vinpocetine WC) is an official document issued by a regulatory agency to a Vinpocetine manufacturer, verifying that the manufacturing facility of a Vinpocetine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Vinpocetine APIs or Vinpocetine finished pharmaceutical products to another nation, regulatory agencies frequently require a Vinpocetine WC (written confirmation) as part of the regulatory process.
click here to find a list of Vinpocetine suppliers with Written Confirmation (WC) on PharmaCompass.
Vinpocetine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vinpocetine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vinpocetine GMP manufacturer or Vinpocetine GMP API supplier for your needs.
A Vinpocetine CoA (Certificate of Analysis) is a formal document that attests to Vinpocetine's compliance with Vinpocetine specifications and serves as a tool for batch-level quality control.
Vinpocetine CoA mostly includes findings from lab analyses of a specific batch. For each Vinpocetine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vinpocetine may be tested according to a variety of international standards, such as European Pharmacopoeia (Vinpocetine EP), Vinpocetine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vinpocetine USP).
LOOKING FOR A SUPPLIER?
